Consolidated Planning Corp’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$287K Buy
681
+68
+11% +$27.1K 0.04% 153
2026
Q2
$222K Sell
613
-33
-5% -$11.3K 0.03% 146
2026
Q1
$227K Sell
646
-8
-1% -$2.85K 0.04% 136
2025
Q4
$214K Buy
+654
New +$207K 0.02% 195
2025
Q3
– Sell
-4,380
Closed -$1.22M – 195
2025
Q2
$1.22M Sell
4,380
-997
-19% -$282K 0.15% 110
2025
Q1
$1.68M Buy
5,377
+3,628
+207% +$1.07M 0.23% 87
2024
Q4
$456K Sell
1,749
-766
-30% -$227K 0.06% 134
2024
Q3
$811K Buy
2,515
+1,842
+274% +$603K 0.12% 101
2024
Q2
$210K Buy
+673
New +$198K 0.03% 180
2024
Q1
– Sell
-728
Closed -$210K – 185
2023
Q4
$210K Buy
+728
New +$198K 0.04% 162
2021
Q4
– Sell
-483
Closed -$103K – 84
2021
Q3
$103K Buy
+483
New +$111K 0.07% 99

Other funds holding AMGN

Consolidated Planning Corp's AMGN Position: Q3 2026 in Review

Consolidated Planning Corp increased its Amgen (AMGN) stake by 11% in Q3 2026, buying an estimated $27.1K and bringing the position to 681 shares worth $287K. The position accounts for 0.04% of the portfolio, ranked #153.

Consolidated Planning Corp first reported a position in AMGN in Q3 2021 and has held it in 11 quarters since. The position peaked at $1.68M in Q1 2025. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Consolidated Planning Corp held 681 shares of Amgen worth $287K as of Q3 2026.
  • Consolidated Planning Corp bought 68 Amgen shares in Q3 2026, an estimated $27.1K.
  • Amgen made up 0.04% of Consolidated Planning Corp's portfolio in Q3 2026, its #153 holding.
  • Consolidated Planning Corp first reported a position in Amgen in Q3 2021 and has held it in 11 quarters since.
  • Consolidated Planning Corp's Amgen position peaked at $1.68M in Q1 2025.
  • 2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Consolidated Planning Corp's 13F filing for Q3 2026, filed 21 Oct 2026.